This inventor holds 25 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 24 EPO patents, primarily in Cancer Therapeutics. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh, Bayer Aktiengesellschaft. Active years: 2000-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
15 out of 387 
9 out of 721 
3 out of 12,268 
Years Active: 2000-2025
Areas of Expertise:
Title: The Innovative Work of Roland Neuhaus
Introduction
Roland Neuhaus, based in Berlin, Germany, is a prolific inventor known for his contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 24 patents, Neuhaus has been at the forefront of developing innovative compounds aimed at treating various medical conditions, particularly those related to cancer and neurogenic diseases.
Latest Patents
Neuhaus's latest patents showcase his expertise in creating novel pharmaceutical compounds. One of his notable inventions includes the development of substituted pyrrolopyridine derivatives. This invention focuses on creating protein-inhibitory compounds that can be used for the treatment and prophylaxis of various diseases, especially neoplastic disorders and conditions associated with dysregulated immune responses. The patent emphasizes the potential application of these compounds in manufacturing pharmaceutical compositions for various disorders, including cancer and various autoimmune and inflammatory conditions.
Another significant patent includes pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors. This invention covers the preparation and application of these compounds to create pharmaceutical compositions aimed at treating neurogenic diseases, either as standalone agents or in combination with other active ingredients.
Career Highlights
Throughout his career, Roland Neuhaus has contributed significantly to leading companies in the pharmaceutical industry. Notably, he has worked with Bayer Pharma and Bayer Intellectual Property GmbH. These experiences have provided him with valuable insights and opportunities to further his innovative work in drug development.
Collaborations
Neuhaus's groundbreaking work has often involved collaboration with esteemed professionals in his field. Notable colleagues include Hartmut Rehwinkel and Olaf Panknin, with whom he has shared ideas and research, further enhancing the reach and impact of their collective contributions to pharmaceutical advancements.
Conclusion
With his extensive patent portfolio and continuous innovation in pharmaceutical sciences, Roland Neuhaus stands out as a prominent inventor. His recent works not only reflect his dedication to addressing critical health challenges but also highlight his significant role in advancing medical research and product development. As he continues to push the boundaries of science, Neuhaus's contributions will likely lead to even more groundbreaking treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile